TMBIM6-mediated miR-181a expression regulates breast cancer cell migration and invasion via the MAPK/ERK signaling pathway
Yeokyung Shin, Hye Yeon Choi, Yeonjoo Kwak, Gwang‐Mo Yang, Yeojin Jeong, Tak-Il Jeon, Jaekwon Seok, Eung-Ryoung Lee, Jung‐Hyun Kim, Kilsoo Jeon, Ahmed Abdal Dayem, Kyung Min Lim, Ssang‐Goo Cho · Journal of Cancer · 2023
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2023
Abstract
Transmembrane Bax Inhibitor Motif-containing 6 (TMBIM6) has been reported to regulate cell death pathways and is overexpressed in several types of cancers.In this study, we investigated whether high expression of TMBIM6 in breast cancer was significantly associated with cancer invasiveness.Knockdown of TMBIM6 reduced proliferation and migration of invasive breast cancer cells through downregulation of the MAPK/ERK signaling pathway.Moreover, we suggested that expression of miR-181a was significantly suppressed upon TMBIM6 knockdown.In contrast, overexpression of TMBIM6 significantly increased cell invasion and migration through up-regulation of mesenchymal markers and matrix metalloproteinase-9 (MMP-9) and enhanced activation of the MAPK/ERK signaling pathway.We also observed that up-regulation of TMBIM6 significantly increased the expression of miR-181a by TMBIM6-mediated pathway.TMBIM6 and miR-181a-mediated ERK activation induced the expression of Snail-1 and Snail-2 in FOSL-1/C-JUN-dependent manner.Overall, our data demonstrated that TMBIM6-induced miR-181a up-regulation plays an important role in the efficient modulation of migration and invasion of breast cancer cells.
Open the resolved locator · 10.7150/jca.81600
Metadata licence: OpenAlex metadata (CC0)